Free Trial

Anavex Life Sciences (AVXL) SEC Filings & 10K Form

Anavex Life Sciences logo
$11.20 -0.10 (-0.88%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$11.15 -0.05 (-0.45%)
As of 08/1/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Anavex Life Sciences SEC Filings

DateFilerForm TypeView
07/23/2025
11:15 PM
Anavex Life Sciences (Filer)
Form EFFECT
07/14/2025
3:30 PM
Anavex Life Sciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2025
4:25 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:30 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
4:30 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2025
3:40 PM
Anavex Life Sciences (Filer)
Form ARS
04/25/2025
3:31 PM
Anavex Life Sciences (Filer)
Form DEF 14A
04/02/2025
8:45 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:45 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:46 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:46 PM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:47 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
8:30 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:06 AM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/17/2025
8:12 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:14 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
6:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
6:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:30 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/06/2024
8:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:21 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVXL) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners